| Vemurafenib in pediatric patients with BRAFV600E mutated high‐grade gliomas F Bautista, A Paci, V Minard‐Colin, C Dufour, J Grill, L Lacroix, P Varlet, ... Pediatric blood & cancer 61 (6), 1101-1103, 2014 | 155 | 2014 |
| Does chemotherapy affect the visual outcome in children with optic pathway glioma? A systematic review of the evidence L Moreno, F Bautista, S Ashley, C Duncan, S Zacharoulis European Journal of Cancer 46 (12), 2253-2259, 2010 | 112 | 2010 |
| First-in-human, first-in-child trial of autologous MSCs carrying the oncolytic virus Icovir-5 in patients with advanced tumors D Ruano, JA López-Martín, L Moreno, Á Lassaletta, F Bautista, M Andión, ... Molecular Therapy 28 (4), 1033-1042, 2020 | 90 | 2020 |
| Outcome of children with relapsed or refractory neuroblastoma: a meta‐analysis of ITCC/SIOPEN European phase II clinical trials L Moreno, H Rubie, A Varo, MC Le Deley, L Amoroso, A Chevance, ... Pediatric Blood & Cancer 64 (1), 25-31, 2017 | 76 | 2017 |
| Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study N Gaspar, R Venkatramani, S Hecker-Nolting, SG Melcon, F Locatelli, ... The Lancet Oncology 22 (9), 1312-1321, 2021 | 74 | 2021 |
| Medulloblastoma in children and adolescents: a systematic review of contemporary phase I and II clinical trials and biology update F Bautista, V Fioravantti, T de Rojas, F Carceller, L Madero, A Lassaletta, ... Cancer medicine 6 (11), 2606-2624, 2017 | 59 | 2017 |
| Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)☆ N Gaspar, Q Campbell-Hewson, SG Melcon, F Locatelli, R Venkatramani, ... ESMO open 6 (5), 100250, 2021 | 45 | 2021 |
| Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome–positive chronic myeloid leukemia N Hijiya, A Maschan, C Rizzari, H Shimada, C Dufour, H Goto, HJ Kang, ... Blood, The Journal of the American Society of Hematology 134 (23), 2036-2045, 2019 | 44 | 2019 |
| Re-irradiation of recurrent pediatric ependymoma: modalities and outcomes: a twenty-year survey MJ Lobón, F Bautista, F Riet, F Dhermain, S Canale, C Dufour, ... Springerplus 5, 1-9, 2016 | 43 | 2016 |
| Inotuzumab ozogamicin as single agent in pediatric patients with relapsed and refractory acute lymphoblastic leukemia: results from a phase II trial E Pennesi, N Michels, E Brivio, VHJ van der Velden, Y Jiang, A Thano, ... Leukemia 36 (6), 1516-1524, 2022 | 41 | 2022 |
| Patients in pediatric phase I and early phase II clinical oncology trials at Gustave Roussy: a 13-year center experience F Bautista, A Di Giannatale, N Dias-Gastellier, M Fahd, ... Journal of pediatric hematology/oncology 37 (2), e102-e110, 2015 | 38 | 2015 |
| Phase I or II study of ribociclib in combination with topotecan-temozolomide or everolimus in children with advanced malignancies: arms A and B of the AcSé-ESMART trial F Bautista, X Paoletti, J Rubino, C Brard, K Rezai, S Nebchi, N Andre, ... Journal of Clinical Oncology 39 (32), 3546-3560, 2021 | 27 | 2021 |
| Managing adverse events associated with dinutuximab beta treatment in patients with high-risk neuroblastoma: practical guidance G Barone, A Barry, F Bautista, B Brichard, AS Defachelles, F Herd, ... Pediatric Drugs 23, 537-548, 2021 | 25 | 2021 |
| Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: a report from the Innovative Therapies for Children with Cancer (ITCC) consortium A Rubio-San-Simón, N André, MG Cefalo, I Aerts, A Castañeda, ... European Journal of Cancer 141, 82-91, 2020 | 23 | 2020 |
| Prognostic factors of overall survival in children and adolescents enrolled in dose-finding trials in Europe: an innovative therapies for children with cancer study F Carceller, FJ Bautista, I Jiménez, R Hladun-Álvaro, C Giraud, ... European Journal of Cancer 67, 130-140, 2016 | 23 | 2016 |
| Multidisciplinary consensus on optimising the detection of NTRK gene alterations in tumours P Garrido, R Hladun, E De Álava, R Álvarez, F Bautista, F López-Ríos, ... Clinical and Translational Oncology 23, 1529-1541, 2021 | 22 | 2021 |
| Blinatumomab and inotuzumab for B cell precursor acute lymphoblastic leukaemia in children: a retrospective study from the Leukemia Working Group of the Spanish Society of … JL Fuster, A Molinos‐Quintana, C Fuentes, JM Fernández, P Velasco, ... British Journal of Haematology 190 (5), 764-771, 2020 | 22 | 2020 |
| Retained intravascular fragments after removal of indwelling central venous catheters: a single institution experience F Bautista, J Gómez-Chacón, E Costa, L Moreno, A Cañete, MD Muro, ... Journal of pediatric surgery 45 (7), 1491-1495, 2010 | 22 | 2010 |
| Challenges in early phase clinical trials for childhood cancer during the COVID-19 pandemic: a report from the new agents group of the Spanish Society of Paediatric Haematology … A Rubio-San-Simon, J Verdú-Amorós, R Hladun, A Juan-Ribelles, ... Clinical and Translational Oncology 23, 183-189, 2021 | 15 | 2021 |
| Clinical research tools in pediatric oncology: challenges and opportunities T de Rojas, A Neven, AJ Towbin, F Carceller, F Bautista, D Riedl, ... Cancer and Metastasis Reviews 39, 149-160, 2020 | 15 | 2020 |
